KMT2A and acute leukemia: It has been reported that the Menin functions as a critical oncogenic co-factor of mixed lineage leukemia (MLL) fusion proteins in development of acute leukemia, and inhibition of the Menin-MLL interaction is a promising strategy to reverse their oncogenic activity [22].